Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CDT

Conduit Pharmaceuticals Inc

Dec 08 • 04:00PM ET

5.15

Dollar change +1.61
Percentage change 45.48	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	233.03	EPS (ttm)	0.02	Insider Own	87.20%	Shs Outstand	13.98M	Perf Week	-6.53%
Market Cap	15.14M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.38M	Perf Month	273.19%
Income	0.55M	PEG	-	EPS next Q	-	Inst Own	21.31%	Short Float / Ratio	12.80% / 0.10	Perf Quarter	-52.23%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	2.63%	Short Interest	0.05M	Perf Half Y	-50.34%
Book/sh	2.73	P/B	1.89	EPS next Y	-	ROA	0.68%	Target Price	-	Perf Year	-48.24%
Cash/sh	0.10	P/C	54.08	EPS next 5Y	-	ROE	0.73%	52W Range	0.95 - 25.00	Perf YTD	-49.76%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	3.21%	52W High	-79.40%	Beta	2.58
Dividend %	-	Quick Ratio	0.17	Sales past 5Y	0.00%	Gross Margin	-	52W Low	442.11%	ATR	1.00
Employees	3	Current Ratio	0.17	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	63.56	Volatility	46.56% 31.51%
Optionable	No	Debt/Eq	0.04	EPS Q/Q	-708.82%	Profit Margin	-	Rel Volume	3.29	Prev Close	3.54
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	0.00%	Avg Volume	472.03K	Price	5.15
Recom	-	SMA20	115.05%	SMA50	118.20%	SMA200	-39.14%	Volume	1,552,738	Change	45.48%

Nov-02-23 08:30AM	Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference (GlobeNewswire)
Oct-30-23 08:39AM	Why Is Conduit Pharmaceuticals (CDT) Stock Up 66% Today? (InvestorPlace) +49.52%
Oct-11-23 08:30AM	Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656 (GlobeNewswire) -12.00%
Oct-06-23 09:29AM	Conduit Pharma CEO Tapolczay on Biopharma Differentiation, Pipeline (Exec Edge) -13.83%
08:30AM	Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW) (GlobeNewswire)
09:01AM	Loading…
Sep-22-23 09:01AM	Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination (GlobeNewswire)
Sep-20-23 05:40PM	Murphy Canyon Acquisition Corp. Announces Stockholder Approval of the Proposed Combination with Conduit Pharmaceuticals Limited (ACCESSWIRE) -8.94%
Sep-13-23 08:30AM	Presidio Property Trust, Inc. Announces Establishment of a Special Committee of the Board and Exploration of Strategic Alternatives (GlobeNewswire)
Sep-07-23 04:30PM	Murphy Canyon Acquisition Corp. Announces Postponement of Its Special Meeting of Stockholders for Approving Its Initial Business Combination With Conduit (ACCESSWIRE)
Aug-31-23 04:05PM	Murphy Canyon Acquisition Corp. Announces Postponement of its Special Meeting of Stockholders for Approving its Initial Business Combination with Conduit (ACCESSWIRE)
Aug-16-23 08:30AM	SEC Declares Form S-4 Registration Statement "Effective" for Proposed Business Combination of Murphy Canyon Acquisition Corp. with Conduit Pharmaceuticals Limited (ACCESSWIRE)

Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships. Its medical needs in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Heilbron Jack Kendrick	Former CEO,director&10% owner	Sep 22	Option Exercise	0.00	4,060,250	0	4,060,250	Sep 26 05:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CDT

Conduit Pharmaceuticals Inc

Upgrade your FINVIZ experience